Silence Therapeutics PLC (SLN)
13.98
-1.30
(-8.54%)
USD |
NASDAQ |
Nov 14, 16:00
13.98
0.00 (0.00%)
After-Hours: 20:00
Silence Therapeutics Total Assets (Quarterly): 238.59M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 238.59M |
| March 31, 2024 | 245.40M |
| December 31, 2023 | 119.52M |
| September 30, 2023 | 119.50M |
| June 30, 2023 | 116.94M |
| March 31, 2023 | 116.84M |
| December 31, 2022 | 130.10M |
| September 30, 2022 | 138.51M |
| June 30, 2022 | 101.16M |
| March 31, 2022 | 114.00M |
| December 31, 2021 | 129.83M |
| September 30, 2021 | 124.54M |
| June 30, 2021 | 139.40M |
| June 30, 2021 | 139.40M |
| December 31, 2020 | 117.16M |
| June 30, 2020 | 123.20M |
| June 30, 2020 | 123.20M |
| December 31, 2019 | 60.41M |
| June 30, 2019 | 38.04M |
| June 30, 2019 | 38.04M |
| December 31, 2018 | 49.34M |
| June 30, 2018 | 62.18M |
| June 30, 2018 | 62.18M |
| December 31, 2017 | 74.34M |
| June 30, 2017 | 66.75M |
| Date | Value |
|---|---|
| June 30, 2017 | 66.75M |
| December 31, 2016 | 68.54M |
| June 30, 2016 | 79.41M |
| June 30, 2016 | 79.41M |
| December 31, 2015 | 91.18M |
| June 30, 2015 | 99.05M |
| June 30, 2015 | 99.05M |
| December 31, 2014 | 46.34M |
| June 30, 2014 | 59.03M |
| June 30, 2014 | 59.03M |
| December 31, 2013 | 48.32M |
| June 30, 2013 | 50.94M |
| June 30, 2013 | 50.94M |
| December 31, 2012 | 27.59M |
| June 30, 2012 | 14.04M |
| June 30, 2012 | 14.04M |
| December 31, 2011 | 51.52M |
| June 30, 2011 | 58.57M |
| December 31, 2010 | 52.41M |
| June 30, 2010 | 55.63M |
| December 31, 2009 | 17.78M |
| June 30, 2009 | 20.77M |
| December 31, 2008 | 21.06M |
| June 30, 2008 | 29.93M |
| December 31, 2007 | 38.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
60.41M
Minimum
Dec 2019
245.40M
Maximum
Mar 2024
133.21M
Average
123.20M
Median
Jun 2020
Total Assets (Quarterly) Benchmarks
| NuCana PLC | 25.38M |
| TC BioPharm (Holdings) PLC | 9.171M |
| Biodexa Pharmaceuticals PLC | 17.67M |
| Adaptimmune Therapeutics PLC | 321.70M |
| Verona Pharma PLC | 381.82M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 96.29M |
| Shareholders Equity (Quarterly) | 142.30M |
| Current Ratio | 9.830 |